Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 5, 2003, Pages 457-459

  Jakubowska, Anna ^a   Narod, Steven A ^b   Goldgar, David E ^c   Mierzejewski, Marek ^a   Masojć, Bartłomiej ^a   Nej, Katarzyna ^d   Huzarska, Jowita ^a   Byrski, Tomasz ^a   Górski, Bohdan ^a   Lubiński, Jan ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF TORONTO   (Canada)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d UNIVERSITY OF SZCZECIN   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA;

ADULT; ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; DNA REPAIR; DNA STRAND BREAKAGE; FAMILIAL CANCER; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; POLAND; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT;

ADULT; BRCA1 PROTEIN; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MUTATION; POLAND; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RAD51 RECOMBINASE; REGISTRIES; RISK FACTORS;

EID: 0038284651     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Narod, S. A. Modifiers of risk in hereditary breast and ovarian cancer. Nat. Rev. Cancer, 2: 113-123, 2002.
2. Chen, J. J., Silver, D., Cantor, S., Livingston, D, M., and Scully, R. BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway. Cancer Res., 59 (7 Suppl.): 1752-1756, 1999.
3. Maacke, H., Opitz, S., Jost, K., Hamdorf, W., Henning, W., Kruger, S., Feller, A. C., Lopens, A., Diedrich, K., Schwinger, E., and Sturzbecher, H. W. Over expression of wild-type Rad51 correlates with histological grading of invasive ductal breast cancer. Int. J. Cancer, 88: 907-913, 2000.
4. Wang, W. W., Spurdle, A. B., Kolachana, P., Bove, B., Modan, B., Ebbers, S. M., Suthers, G., Tucker, M. A., Kaufman, D. J., Doody, M. M., Tarone, R. E., Daly, M., Levavi, H., Pierce, H., Chetrit, A., Yechezkel, G. H., Chenevix-Trench, G., Offit, K., Godwin, A. K., and Struewing, J. P. A single nucleotide polymorphism in the 5′ untranslated region of RAD51 and risk of cancer among BRCA 1/2 mutation carriers. Cancer Epidemiol. Biomark. Prev., 10: 955-960, 2001.
5. Levy-Lahad, E., Lahad, A., Eisenberg, S., Dagan, E., Paperna, T., Kasinetz, L., Catane, R., Kaufman, B., Beller, U., Renbaum, P., and Gershoni-Baruch, R. A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers. Proc. Natl. Acad. Sci. USA, 98: 3232-3236, 2001.
6. Górski, B., Byrski, T., Huzarski, T., Jakubowska, A., Menkiszak, J., Gronwald, J., Pluzanska, A., Bêbenek, M., Fischer-Maliszewska, L., Grzybowska, E., Narod, S. A., and Lubiñski, J. Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am. J. Hum. Genet., 66: 1963-1968, 2000.
7. Perrin-Vidoz, L., Sinilnikova, O. M., Stoppa-Lyonnet, D., Lenoir, G. M., and Mazoyer, S. The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons. Hum. Mol. Genet., 11: 2805-2814, 2002.
8. Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., and Livingston, D. M. Association of BRCA1 with RAD51 in mitotic and meiotic cells. Cell, 88: 265-275, 1997.